Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care
|ClinicalTrials.gov Identifier: NCT01678118|
Recruitment Status : Active, not recruiting
First Posted : September 3, 2012
Last Update Posted : February 6, 2018
|Condition or disease||Intervention/treatment|
|Minority Smokers||Behavioral: Patient Navigator|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care|
|Actual Study Start Date :||April 2011|
|Estimated Primary Completion Date :||April 2019|
|Estimated Study Completion Date :||April 2019|
A single arm ABA design will be used to pilot a tobacco-focused patient navigation (TPN) intervention for low income, minority smokers.
Behavioral: Patient Navigator
The pt navigator will phone (email, text, or other preferred method of contact) pts prior to the date of previously set individual goals (e.g. going to an appt, getting their cessation medications filled, etc) as a reminder & to discuss barriers such as finances, transportation or ambivalent motivation. In this manner, pts receive navigation services tailored to their individual needs & barriers. Once pts are connected with a cessation service (defined as either using cessation medication or at least 1 contact with a Quitline or community-based cessation counselor)or provider-prescribed cessation medication usage, continues the navigation intervention will be considered complete. W/I the 3 month engagement period, pts will receive up to 6 contacts from the Pt Navigator following referral from primary care provider. Consistent with recommended pt navigation practice, the navigator will provide feedback to primary care provider regarding cessation services that the pts are receiving.
- patient navigation (TPN) feasibility [ Time Frame: 1 year ]To evaluate the study's potential in terms of its reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) of the intervention, tobacco-dependent patients will be asked to complete an intake interview and a telephone follow-up interview (at 3 to 6 months post-intervention).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678118
|United States, New York|
|Heritage Health Center|
|New York, New York, United States, 10031|
|Ralph Lauren Center for Cancer Care and Prevention|
|New York, New York, United States|
|Principal Investigator:||Jamie Ostroff, PhD||Memorial Sloan Kettering Cancer Center|